Patents by Inventor Robert C. Mierendorf

Robert C. Mierendorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7008651
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Grant
    Filed: May 3, 2001
    Date of Patent: March 7, 2006
    Assignee: EMD Biosciences, Inc.
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf
  • Publication number: 20020034559
    Abstract: There is now a market for kits containing the necessary components for performing protein synthesis reactions using template DNA of the experimenter. One category of existing system for performing protein synthesis reactions is based on an S-30 extract from the bacteria E. coli. It is disclosed here that a simple fractionation process can dramatically improve the performance of an S-30 prokaryotic protein synthesis reaction mixture. In one embodiment, the fractionation is a simple freezing and thawing of an S-30 extract combined with a supplemental mix, followed by centrifugation. The resulting fractionated S-30 reaction mixture yields more full-length target protein and less non-full length or non-target protein than possible using prior art S-30 systems.
    Type: Application
    Filed: May 3, 2001
    Publication date: March 21, 2002
    Inventors: Yuping Ambuel, Thomas R. Van Oosbree, Mark R. McCormick, Robert C. Mierendorf
  • Patent number: 6103878
    Abstract: An antibody raised against an epitope of a peptide having an amino acid sequence selected from a group consisting of Leu Asp Gly Tyr Pro Ser Asp Tyr Asp Pro Phe Val Glu Asn Ala Gln Ile Tyr (SEQ ID NO:1) and Leu Asp Gly Tyr Pro Ser Asp Tyr Asp Pro Phe Glu Glu Asn Ala Gln Ile Tyr (SEQ ID NO:2) is advantageously used in an indirect immunoassay to detect the presence of active Human Herpesvirus-6 in a patient sample.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: August 15, 2000
    Assignee: Pel-Freez Rabbit Meat, Inc.
    Inventors: Gary L. Milburn, Robert E. Novy, Jr., Robert C. Mierendorf, Jr.
  • Patent number: 5856144
    Abstract: A vector for the direct cloning of the products of PCR protocol incorporates single nucleotide overhangs at one or both ends of a linearized DNA segment. The single nucleotide overhangs are uracil or inosine residues, as desired, to facilitate cloning of the desired PCR products.
    Type: Grant
    Filed: June 18, 1997
    Date of Patent: January 5, 1999
    Assignee: Novagen, Inc.
    Inventors: Robert C. Mierendorf, Robert E. Novy, Kristin M. Kolb, David O'Reilly
  • Patent number: 5756302
    Abstract: An antibody raised against an epitope of a peptide having an amino acid sequence selected from a group consisting of LDGYPSDYDPFVENAQIY (SEQ ID NO:1) and LDGYPSDYDPFEENAQIY (SEQ ID NO:2) is advantageously used in an indirect immunoassay to detect the presence of active Human Herpesvirus-6 in a patient sample.
    Type: Grant
    Filed: July 16, 1996
    Date of Patent: May 26, 1998
    Assignee: Pel-Freez Rabbit Meat, Inc.
    Inventors: Gary L. Milburn, Robert E. Novy, Jr., Robert C. Mierendorf, Jr.
  • Patent number: 5629179
    Abstract: A method for forming directionally clonable randomly primed cDNA molecules includes the step of priming first strand synthesis using a set of first strand cDNA primers having the sequence 5'-XXNNNNNN-3' where XX is a constant dinucleotide pair across the set and NNNNNN is a random hexanucleotide, the set including primers representing all random hexanucleotides.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: May 13, 1997
    Assignee: Novagen, Inc.
    Inventors: Robert C. Mierendorf, Barbara B. Morris